chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a 70 year old female registered nurse concerning herself. The patient had arthritis, depression, unspecified digestive problems, asthma, osteoporosis, precancerous esophagus, hypothyroidism and allergic to penicillin. The patient's medical history included bowel obstruction. The nurse stated that she had previously received a dose of PNEUMOVAX23 (lot number, dose, route and injection site were not reported) about 5 years ago (in approximately March 2008) with no adverse reactions. On 31-JAN-2013 the patient was vaccinated with PNEUMOVAX23 (lot number was not reported) (0.5 ml in the left arm) by unknown route. Concomitant therapies included SYNTHROID. On 31-JAN-2013, 5 hrs after receiving a dose of PNEUMOVAX23 the patient experienced severe pain in her left shoulder. At 3:00 AM, on 01-FEB-2013 the patient woke up with all of her joints swollen and very painful. The patient was evaluated in the emergency room of the Hospital and admitted. The PNEUMOVAX23 injection was administered "high" on her left arm, and "did not go into muscle" but was not administered subcutaneously. She could not provide a definite route of administration. A Magnetic resonance imaging (MRI) showed a "hole" in her left, upper, arm bone, and that she had very little range of motion in her left shoulder. The patient also stated that a few days after receiving PNEUMOVAX23 she was diagnosed with a bowel obstruction and a nasogastric (NG) tube was inserted. The patient stated that she had a history of bowel obstruction. Treatment extra strength TYLENOL and CELEBREX were given for adverse events. Lab diagnostics studies X-ray and MRI of left shoulder were performed. The outcome was reported as recovering. Action taken and causality were not provided at the time of report. The patient had a phone call to physician then visited to emergency room. Adverse events were considered serious as significant disability or incapacity, and the patient was hospitalized. Additional information has been requested.
On the same day, my arm started hurting in the afternoon after the vaccine. My lymph nodes started hurting and it was swollen and painful . This was on the left side. Body aches. It excruciating pain and it was awful. I called my pharmacy, they suggested Ibuprofen and to ice the area. Every time, my body was underwater it felt like your armpit was fire and had a burning pain. This 5 or 6days.
Joint pain worsening; chills; body aches; This spontaneous case was reported by an other health care professional and describes the occurrence of ARTHRALGIA (Joint pain worsening), CHILLS (chills) and MYALGIA (body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 02620A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since January 1995 and Osteoarthritis (increasingly worse after vaccination.) since November 2014. Concomitant products included DICLOFENAC (VOLTAREN [DICLOFENAC]) for Arthritis, METABOLIFE for Weight loss.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced ARTHRALGIA (Joint pain worsening), CHILLS (chills) and MYALGIA (body aches). On 07-Feb-2021, CHILLS (chills) and MYALGIA (body aches) had resolved. At the time of the report, ARTHRALGIA (Joint pain worsening) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Heart rate: increased (High) Increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided   This case was linked to MOD-2021-074674 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: no new information On 08-Jul-2021: Follow-up information received on 08 Jul 2021 contains significant information : Reporter Information, Other Relevant History and concomitant drug and events are added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient received her Moderna vaccine and within 30 minutes developed hives, itching, and a dry mouth. Diphenhydramine 25 mg PO administered; patient was brought to ED for treatment.  No airway compromise.  In ED, patient received famotidine 20 mg IV one-time, methylprednisolone 125 mg IV one-time., and NS infusion.
pt recvd vax 6SEP94 & w/in 24hrs exp flu-like sx w/fever,cough,noc sweats,joint pains,anorexia,malaise;APAP given;sx persists;
Initial and follow up information has been received from a licensed visiting nurse concerning a 78 year old retired white female with a general symptom, "Wygesic".  On 26-SEP-2005, at 10:30 am, the patient was vaccinated intramuscularly into the right deltoid with the first dose of pneumococcal 23v polysaccharide vaccine (Lot#649979/0531P).  On 26-SEP-2005, the patient developed injection site reaction.  The patient was treated with a topical cream. On 26-SEP-2005, at 7:00 pm, the patient developed itching, redness at injection site. swelling and pain.  On 27-SEP-2005, in the am, the patient reported "difficult to use arm", increased heart rate and increased blood pressure.  The patient sought unspecified medical attention.  On 28-SEP-2005, the patient recovered from the events.  No further information is available.
The patient reported no current adverse event or any effect experienced requiring medical attention. The patient instructed to contact the pharmacy if any adverse events occurred.
Incredible painful chest pain - he was bent over on his hands and knees.  He was taken to the hospital.
Immediate onset of anterior chest tightness and sensation of throat closing/fullness; tachycardia. This lasted for an hour or so and she was monitored in the ED at the hospital where the vaccine was given. No drugs given and was released 2 hours later. Another episode happened while driving and self-resolved on the way home. Did well overnight, including 10 minutes of exercise on a rowing machine. This morning went to work and about 2 hours after arrival had chest discomfort followed an hour later by symptomatic tachycardia and went to ED within that same facility where she works. Nursing reported "SVT" on ECG and then sent her to our clinic as one of our docs is her PCP. Her ECG was clearly not SVT, showing 1 PVC and heart rate of 85 and 97 on 2 separate tracings. No labs or meds given on either ED visit.
Patient was 16  years old and 8 mos.   The mother was present and requested that Moderna be given and was given a VIS for her and for her Son receiving Moderna.  They proceeded with Vaccination.  After the vaccination, the vaccinator realized the patient was actually younger than he looked as she was entering in the documentation / demographics.  She promptly called the mother and informed her of the facts of Moderna for 18 and up however, per CDC the recommendations are for the 2nd Moderna to be given as per normal in 4 weeks.  No side effects and no afteraffects.  Encouraged mom to call if any issues.
COVID-19; COVID-19; This is a spontaneous report received from contactable healthcare professional. The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 02Oct2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 59 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Functional heart murmur" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "recovered with sequelae" (2023) and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included nirmatrelvir/ ritonavir (PAXLOVID; Lot Number: GK2931) from 25Jul2023 to 30Jul2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
CONJUNCTIVITIS; BACK PAIN; SEVERE REACTION; JOINT PAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 29-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the patient experienced conjunctivitis. On MAY-2021, the patient experienced back pain. On MAY-2021, the patient experienced severe reaction. On MAY-2021, the patient experienced joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain, back pain, and conjunctivitis, and the outcome of severe reaction was not reported. This report was non-serious.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.
VACCINE ADMINISTERED 13 HOURS AFTER INITIAL PUNCTURE; INCORRECTLY STORED VACCINE ADMINISTRATED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 211D21A expiry: 11-APR-2022) dose was not reported, administered on 28-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-DEC-2021, the patient experienced vaccine administered 13 hours after initial puncture, and incorrectly stored vaccine administrated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered 13 hours after initial puncture and incorrectly stored vaccine administrated was not reported. This report was non-serious.
Hypertensive (167/91), tachycardia HR of 126, flushing, dizzy, dry mouth, sweating.  patient refused further care and her symptoms improved then left the waiting area at 2:55pm.  Before leaving, her vitals were BP 133/69, HR 70 and SpO2 100% on room air.
Brief period of dizziness and shortness of breath.  Symptoms resolved within minutes without treatment; did not reoccur.
Initial information received on 18-Jan-2019 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves Adult patient who experienced blue color limbs and loss of feeling in the extremities, while received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number and Expiry date unknown) via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious blue color limbs and loss of feeling in the extremities (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. (Other relevant tests included No lab data). Final diagnosis was loss of feeling in the extremities and blue color limbs. It was not reported if the patient received a corrective treatment. The event outcome was reported as Unknown. List of documents held by sender: none.
I got up at 6:20 am on Thursday walked downstairs started to feel very hot, sweaty, and  nauseas.  I passed out without  a chance to sit down this happened at 6:30 am.  I did not seeing it coming.  After this incident I was feeling better just tired for the rest of the day. By Friday I was feeling like my normal self.
Experiencing ongoing joint swelling, knuckles and fingers, ankles and knees.  Difficulty closing hand.  Discoloration of middle finger, skin taut. Tightness and "wrist cracking" keeping her up at night.  Strength very decreased.  Saw PCP, had panel of blood work for arthritis, illness, all came back negative.
One week after injection it started with pain in left armpit, chills at night, swelling in injection site, itching and pain at injection site. Next day I started to get joint pain in shoulders, neck, elbows, fingers. Next day the joint pain was severe and into the night became debilitating. following day I was still incapacitated with extreme joint pain so that I thought I had Lyme disease. I've had it before and indeed was bit one week before my injection. Lyme test taken days later and came back negative. Now, one week after onset of side effects I still have joint pain that is worse than normal for me, though I have improved greatly. The extreme joint pain I had started to dissipate after 3 days, but was so bad I could not lift my arms or hold onto things.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The date of vial placed in refrigerator was on 14-OCT-2021 and vaccine did not undergone any temperature excursion. Patient did not experience any adverse event. No concomitant were reported. No treatment were reported.
Pt vaccinated with TTA developed swollen area - exudate expressed; Tx duricef. Then sent to an Infectious Disease Consult who cultured area Staph. Employee is still off on disability. Area still forming scab.
The patient had symptoms start 5 minutes after the vaccine was administered. The patient was diaphoretic, his blood pressure dropped 20 systolic, he stated he was weak, he was dry heaving and having difficulty breathing. He was administered an Epi-pen by the nurse. The patient stayed in the office for 45 minutes and was evaluated by the physician. After waiting 45 minutes the patient stated he felt good and wanted to go home.
High fever; lethargic; nausea; upset stomach; severe headache; body aches; restless; very weak; dizziness; could not move arm that shot was received in; This is a spontaneous report received from a contactable consumer(patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE,  solution for injection; lot number and expiry were reported) via an unspecified route of administration, at the age of 61-year-old, on  08Sep2021 18:45, at the left arm, at dose number unknown, single for covid-19 immunisation in a Pharmacy/drug store. The patient had no known allergies. The patient's medical history was not reported. Concomitant medications in two weeks included hydrocodone bitartrate, paracetamol (NORCO), diazepam, bupropion hydrochloride (WELLBUTRIN), gabapentin and progesteron. The patient is not pregnant at the time of vaccination. The patient did not any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have prior COVID vaccination and was not tested post vaccination. On 08Sep2021 at 23:00, the patient experienced High fever, lethargic, nausea, upset stomach, severe headache, body aches, restless, very weak, dizziness, could not move arm that shot was received in. The patient did not receive treatment in response to the events. The outcome of the events was not recovered at the time of report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
No known adverse reaction noted by parents. Patient received PCV-7 that had been exposed to freezing refrigerator temp. Parent notified CDC and manufacturer contacted. Patient to receive repeat vaccination at 18 months WCC per doctor.
Ache in Shoulders, extreme discomfort in upper torso - diagnosed with Pericarditis
This is a spontaneous report from a contactable consumer via medical information. A 76-year-old female patient of an unspecified ethnicity received PREVNAR13 via an unspecified route of administration on an unspecified date. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced rapid heart rate and shortness of breath while walking on steps and also while laying in bed. The outcomes of the events, rapid heart rate and shortness of breath were unknown.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 32-year-old female subject who was vaccinated with Flulaval for prophylaxis. The healthcare professional is the subject. The subject reported that she had received influenza virus vaccine in previous years and experience transient low-grade fever and aches. Concurrent medications included Yaz. On 22 October 2007 the subject received unspecified dose of Flulaval (.5 ml, unknown, left arm). On 23 October 2007, within 24 hours after vaccination with Flulaval, the subject experienced injection site redness, injection site soreness, and injection site warmth. The subject was seen by a physician. The subject stated that she did not experience the fever and aches that she had experienced with previous influenza vaccinations. At the time of reporting the events were unresolved. The subject also reported a product complaint because she is concerned over the potential for a contaminated or defective product. The healthcare professional considered the events were probably related to vaccination with Flulaval.
This case was reported by a consumer via call center representative and described the occurrence of pain in thumb in a 81-year-old female patient who received SHINGRIX (batch number Z9RR4, expiry date 30th November 2018) for prophylaxis. On 21st June 2018, the patient received SHINGRIX. On 21st June 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain and injection site warmth. On 3rd July 2018, the patient experienced pain in thumb, knee pain, tingling of extremity and stiff joint. The patient was treated with prednisone. On an unknown date, the outcome of the pain in thumb, injection site pain, knee pain, injection site warmth, tingling of extremity and stiff joint were unknown. It was unknown if the reporter considered the pain in thumb, injection site pain, knee pain, injection site warmth, tingling of extremity and stiff joint to be related to SHINGRIX. Additional details were received as follows: The patient reported that she experienced injection site pain on the day of the SHINGRIX vaccination. The patient also reported that the injection site was felt warm. The patient began to experience left thumb pain in the injected arm. The patient also reported that some joint pain in the hand as well. She reported that her left knee had an ache behind the knee. The patient also reported some tingling in the left hand. The patient saw her rheumatologist, who prescribed low dose of prednisone.
The day after shot I just had mild symptoms , bad headache and very tired.  The next day I woke up with a severe rash all over my chest, neck, stomach, back and arms. It was very bumpy, red and lumpy.  It did not itch and I don't think I had a fever.  I actually felt better this day than the day before.  I've heard of rashes just localized on your arm where the injection site was but not all over.  That night I took a benyadryl and it helped a lot.  It's almost gone.  Thought it was a strange reaction and just wanted to report it because I haven't heard of this before.
Stiff neck/shoulder pain, trouble breathing ( few hours after) and clusters of discoloration on my arm the next day after vaccination.  The discoloration still persists.
Reaction: 1 hour after her first Moderna vaccine on 6/19/21, patient developed a significantly pruritic rash in her extremities and trunk.  Shortly after that developed abdominal pain, nausea and vomiting x2.  administered Epinephrine autoinjector in ED. Tryptase was normal (2.2). Query biphasic reaction: 5 days later, had diarrhea and rash; administered Epinephrine in ED again and monitored.
A week later, flu like symptoms: slight fever ( 99-100)r joint and muscle aches and pains, fatigue, poor appetite, chills intermittent sharp pain jabs throughout body and head. Rx: one dose of extra str. Tylenol, inc. fluids and sleep/ rest. Feel better tonight: took a shower after 3 days and am able to eat better.
Information has been received from a physician concerning a 24 year old patient who on 27 Nov 2006 was vaccinated in the arm with the first dose of HPV Vaccine. There was no concomitant medications. On 28 Nov 2006, it was reported that the patient developed generalized itching throughout her body. The patient called the physician on the following day and reported she was itchy. The physician stated that she believed the patient experienced an allergic reaction and dose not want to give the second and third shot. It was reported that the patient sought unspecified medical attention. It was reported that a couple of days later, the patient had recovered. Additional information has been requested.